Edwards Lifesciences (EW) Tops Q2 EPS by 5c; offers guidance
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $94.37 +2.59%
EPS Growth %: +10.4%
Financial Fact:
Cost of goods sold: 201.4M
Today's EPS Names:
CRMT, More
EPS Growth %: +10.4%
Financial Fact:
Cost of goods sold: 201.4M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.67, $0.05 better than the analyst estimate of $0.62. Revenue for the quarter came in at $1.53 billion versus the consensus estimate of $1.49 billion.
GUIDANCE:
Edwards Lifesciences sees FY2025 EPS of $2.40-$2.50, versus the consensus of $2.47.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight
- Trump: 40-60% of chip manufacturing will be in the U.S. - CNBC Interview
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
